Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerrit Frommeyer

Showing results (71-80 of 209) with videos related to

Pageof 21
Sort By:
International Journal of Cardiology|November 19, 2016
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedaroneGerrit Frommeyer, Dirk Puckhaber, Christian Ellermann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 7, 2017
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, André Mittelstedt, Julian Wolfes, et al.
Journal of Cardiovascular Electrophysiology|January 10, 2018
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndromeGerrit Frommeyer, Julius Krawczyk, Christian Ellermann, et al.
Pharmacology|July 9, 2018
Ranolazine Prevents Levosimendan-Induced Atrial FibrillationChristian Ellermann, Anja Kohnke, Dirk G Dechering, et al.
European Journal of Pharmacology|February 25, 2016
Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmiaGerrit Frommeyer, Christina Fischer, Philipp S Lange, et al.
Pacing and Clinical Electrophysiology : PACE|March 13, 2025
Long-Term Follow-Up of the S-ICD: A 10-Years Follow-Up Study of a Large Single Center CohortGerrit Frommeyer, Florian Reinke, Benjamin Rath, et al.
Cardiovascular Toxicology|February 11, 2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and DomperidoneGerrit Frommeyer, Christina Fischer, Christian Ellermann, et al.
Journal of Cardiac Failure|December 5, 2012
New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmiaGerrit Frommeyer, Sridharan Rajamani, Fabian Grundmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 1, 2019
Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart diseaseKevin Willy, Florian Reinke, Nils Bögeholz, et al.
Biomed Research International|July 14, 2018
The Transcription Factor ATF4 Promotes Expression of Cell Stress Genes and Cardiomyocyte Death in a Cellular Model of Atrial FibrillationJohanna K Freundt, Gerrit Frommeyer, Fabian Wötzel, et al.
Pageof 21

Showing results (71-80 of 209) with videos related to

Sort By:
Pageof 21
International Journal of Cardiology|November 19, 2016
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedaroneGerrit Frommeyer, Dirk Puckhaber, Christian Ellermann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 7, 2017
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, André Mittelstedt, Julian Wolfes, et al.
Journal of Cardiovascular Electrophysiology|January 10, 2018
Ryanodine-receptor inhibition by dantrolene effectively suppresses ventricular arrhythmias in an ex vivo model of long-QT syndromeGerrit Frommeyer, Julius Krawczyk, Christian Ellermann, et al.
Pharmacology|July 9, 2018
Ranolazine Prevents Levosimendan-Induced Atrial FibrillationChristian Ellermann, Anja Kohnke, Dirk G Dechering, et al.
European Journal of Pharmacology|February 25, 2016
Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmiaGerrit Frommeyer, Christina Fischer, Philipp S Lange, et al.
Pacing and Clinical Electrophysiology : PACE|March 13, 2025
Long-Term Follow-Up of the S-ICD: A 10-Years Follow-Up Study of a Large Single Center CohortGerrit Frommeyer, Florian Reinke, Benjamin Rath, et al.
Cardiovascular Toxicology|February 11, 2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and DomperidoneGerrit Frommeyer, Christina Fischer, Christian Ellermann, et al.
Journal of Cardiac Failure|December 5, 2012
New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmiaGerrit Frommeyer, Sridharan Rajamani, Fabian Grundmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 1, 2019
Outcome differences and device performance of the subcutaneous ICD in patients with and without structural heart diseaseKevin Willy, Florian Reinke, Nils Bögeholz, et al.
Biomed Research International|July 14, 2018
The Transcription Factor ATF4 Promotes Expression of Cell Stress Genes and Cardiomyocyte Death in a Cellular Model of Atrial FibrillationJohanna K Freundt, Gerrit Frommeyer, Fabian Wötzel, et al.
Pageof 21